3.00BMarket Cap11.56P/E (TTM)
50.480High48.795Low664.50KVolume49.470Open49.440Pre Close32.81MTurnover1.35%Turnover Ratio11.56P/E (Static)61.38MShares60.60052wk High4.44P/B2.41BFloat Cap24.22052wk Low--Dividend TTM49.27MShs Float60.600Historical High--Div YieldTTM3.41%Amplitude4.470Historical Low49.371Avg Price1Lot Size
Protagonist Therapeutics Stock Forum
Protagonist Reports Positive Top Line Results From Phase 2b Study of Icotrokinra Showing Potential to Transform the Treatment Paradigm for Patients With Ulcerative Colitis
Can This New Oral Psoriasis Drug Replace Injectable Treatments? Phase 3 Data Shows Remarkable 46% Complete Clearance
Can This New Drug Cut Blood Draws by 72% for Polycythemia Vera Patients?
Just my thoughts and where I plan to put my money in. $Texas Pacific Land (TPL.US)$, $Arista Networks (ANET.US)$, $Protagonist Therapeutics (PTGX.US)$ , $Tesla (TSLA.US)$ in my play lists tomorrow. The first two have earnings coming up this week as well.
Play safe, make a lot of money Mooers, either side up or down!
No comment yet